Immunopharmacotherapy of non-infectious uveitis: Where do we stand?

Keyphrases

• Non-infectious Uveitis 100%
• Immunopharmacotherapy 100%
• Ocular Inflammatory Disease 100%
• Inflammation 50%
• Immunosuppressive Therapy 50%
• Randomized Controlled Trial 50%
• Personalized Medicine 50%
• Uveitis 50%
• Non-infectious 50%
• Novel Agents 50%
• Ocular Inflammation 50%
• Specific Biomarkers 50%
• Potentially Toxic 50%
• Treatment Modalities 50%
• Biological Agents 50%
• Long-term Adverse Effects 50%
• Sword 50%
• Systemic Immunosuppression 50%
• Personal Experience 50%
• Steroid-sparing 50%
• Vision Threatening 50%
• Strong Inhibition 50%
• Current Practice Patterns 50%
• Tertiary Care Centers 50%
• Evolving Concepts 50%
• Posterior Uveitis 50%
• Control Optimization 50%

Medicine and Dentistry

• Uveitis 100%
• Immunosuppressive Treatment 50%
• Inflammatory Disorder 50%
• Inflammation 50%
• Biological Marker 25%
• Clinician 25%
• Randomized Controlled Trial 25%
• Biological Product 25%
• Personalized Medicine 25%
• Retrospective Study 25%
• Patient Referral 25%
• Adverse Drug Reaction 25%
• Personal Experience 25%
• Treatment Modality 25%
• Steroid 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Uveitis 100%
• Inflammation 50%
• Immunosuppressive Agent 50%
• Inflammatory Disease 50%
• Biological Marker 25%
• Randomized Controlled Trial 25%
• Biological Product 25%
• Retrospective Study 25%
• Adverse Drug Reaction 25%
• Steroids 25%